ENLIVEN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.57 USD | +0.13% |
|
-5.72% | +63.08% |
| 05-20 | Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing | MT |
| 05-14 | Enliven Therapeutics Q1 Loss Narrows | MT |
Chart calendar Enliven Therapeutics, Inc.
8ff5d4e6014cc6b0.T5A3UykWbBxIADOzq_yvKosb4v-Oy3MYkGSoHysjYoM.ENZZEVFZD20dcVT1yJeaaPhtkqXHiQV_4VP_TnRiNuUnz1M2EFAzcDxIdg~b06e99ee2bc865b2bf2b7f58cf37acd4
Upcoming events on Enliven Therapeutics, Inc.
Past events on Enliven Therapeutics, Inc.
| 14/05/2024 21:05 | Q1 2024 Earnings Release |
| 11/04/2024 13:00 | Business Update Call |
| 14/03/2024 20:05 | Q4 2023 Earnings Release |
| 05/03/2024 17:50 | TD Cowen Health Care Conference |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 10/08/2023 21:05 | Q2 2023 Earnings Release |
| 23/06/2023 16:30 | Annual General Meeting |
| 14/06/2023 16:00 | Goldman Sachs Global Healthcare Conference |
| 08/06/2023 16:00 | Jefferies Global Healthcare Conference |
| 12/05/2023 01:05 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -83,5 -85,3 2.08% | -120 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -38,8 -40,0 3.02% | -83,5 -85,9 2.73% | -116 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -37,7 -39,9 5.61% | -71,6 -74,2 3.53% | -103 |
|
Net income Million USD | Released Forecast Spread | -24,7 | -37,7 -39,9 5.61% | -71,6 -74,2 3.53% | -103 |
|
EPS USD | Released Forecast Spread | -3,17 | -3,56 -3,80 6.32% | -2,01 -2,16 7.05% | -2,30 |
| Announcement Date | 10/11/22 | 21/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,4 -12,1 -35.69% | -20,1 -16,4 -23.14% | -24,2 -21,7 -11.57% | -22,7 -25,1 9.34% | -26,0 -25,5 -1.82% | -28,3 | -30,5 | -31,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,7 -12,0 -23.21% | -16,7 -14,9 -12.6% | -20,8 -18,5 -12.25% | -19,4 -22,4 13.52% | -22,7 -23,9 4.9% | -26,1 | -27,8 | -29,1 |
|
Net income Million USD | Released Forecast Spread | -14,7 -12,0 -23.21% | -16,7 -14,9 -12.6% | -20,8 -18,5 -12.25% | -19,4 -22,4 13.52% | -22,7 -23,9 4.9% | -26,1 | -27,8 | -29,1 |
|
EPS USD | Released Forecast Spread | -0,80 -0,52 -53.85% | -0,41 -0,40 -3.36% | -0,51 -0,47 -7.94% | -0,47 -0,54 12.96% | -0,54 -0,57 4.71% | -0,57 | -0,62 | -0,63 |
| Announcement Date | 11/05/23 | 10/08/23 | 09/11/23 | 14/03/24 | 14/05/24 | - | - | - |
More events
Past sector events for Enliven Therapeutics, Inc.
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 13:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ELVN Stock
- Calendar Enliven Therapeutics, Inc.
